Estimated NAVs 28FEB2007

RNS Number:6529S
Dexion Alpha Strategies Limited
09 March 2007

Dexion Absolute Limited (the "Company")



Estimated Net Asset Values



Ordinary Shares



As at the close of business on 28 February 2007, the estimated net asset values
of the Company's ordinary shares are as follows:-


  Share Class           NAV         WTD Performance    MTD Performance    YTD Performance
    # Shares       144.37 pence          -0.32%             +0.83%             +1.98%
   EUR Shares       EUR 2.0769           -0.33%             +0.71%             +1.74%
   US$ Shares       US$ 2.5979           -0.32%             +0.83%             +2.00%
   A$ Shares         A$ 3.6338           -0.30%             +0.86%             +2.14%



These valuations, which have been prepared in good faith by the Company's
investment manager, are for information purposes only and are based on the
unaudited estimated valuations supplied to the Company's investment adviser by
the administrators or managers of the Company's underlying investments. Such
estimates may be subject to little verification or other due diligence and may
not comply with generally accepted accounting practices or other generally
accepted valuation principles. In addition, some of those estimates may not be
supplied on a regular or timely basis with the result that the values of such
investments are based on the latest available estimates which may be some time
before the date set out above. Of the Company's 50 investments. 0 investments
have not been valued within 7 days of the above date. Certain other risk factors
which may be relevant to these valuations are set out in the Company's
prospectus dated 11 August 2006.



Investment Policy



The Company's investment policy is to invest in an actively managed portfolio of
hedge funds which is diversified by investment strategy, style and manager, to
achieve attractive risk adjusted returns with low correlation to equity and
fixed interest benchmarks. The Company does not invest in other UK listed
investment companies (including UK listed investment trusts).



Voting Rights and Capital



The Company's capital consists of 415,771,118 # Shares, 59,496,000 US$ Shares,
69,636,331 Euro Shares and 20,423,152 A$ Shares with voting rights. Therefore, the
total number of voting rights in the Company is 415,771,118 in respect of the #
Shares, 59,496,000 in respect of the US$ Shares, 69,636,331 in respect of the Euro
Shares and 20,423,152 in respect of the A$ Shares.



All Shareholders have equal voting rights based on the number of Shares held.
Accordingly, the total number of voting rights in the Company is 565,326,601 and
this figure may be used by Shareholders as the denominator for the calculations
by which they will determine if they are required to notify their interest in,
or a change to their interest in the Company under the FSA's Disclosure and
Transparency Rules.




                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

NAVIIFVTVTIAIID

Dexion Alpha Strategies (LSE:DASL)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024